Skip to main content
. 2015 Feb 20;55(3):241–247. doi: 10.2176/nmc.ra.2014-0219

Fig. 3.

Fig. 3.

Effect of edaravone on clinical outcome in the patients treated with an endovascular treatment (EVT). The edaravone group tended to have more favorable outcome in the patients treated with EVT, but it was not significant (21.2% vs. 13.9%, p = 0.309).